{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:26:03Z","timestamp":1753892763488,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Since the 1990s there has been evidence of the significant role Flumazenil (FLU) has in benzodiazepines (BZD) detoxes. The Verona Detox approach has been developed for high dose BZD and Z-drug detoxification via continuous subcutaneous infusion of FLU, a selective BZD receptor antagonist acting on the BZD subunit of the GABA-A receptor. Flumazenil is licensed in the United Kingdom and other countries to treat only BZD overdose although numerous studies have demonstrated its effectiveness in rapidly resetting GABA-A receptors, quickly reducing tolerance and dependence from BZD, and providing a safe and rapid detox from benzodiazepines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this article is to provide all healthcare professional who are interested in BZD detoxification with an approach and clear practical information on how to administer FLU.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>In this article we outline the approach in detail, describing all medical and nursing procedures day by day. This detox treatment is indicated for patients abusing from at least 5 Defined Daily Dose (DDD) of BZDs or Z-drugs. The process lasts 7 days, and is conducted under medical supervision (daily reviews) and continuous nursing (24\/7). During this period, 7mg of FLU is administered (1 mg\/24) through an elastomeric pump, via continuous subcutaneous infusion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>To this day, the largest database of FLU detoxification was published by our group, showing how this treatment is safe, with very little side effects even in patients with significant medical comorbidities.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2022.857376","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:44:04Z","timestamp":1648730644000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Addiction of High Dose of Benzodiazepine: Verona Detox Approach With Flumazenil"],"prefix":"10.3389","volume":"13","author":[{"given":"Rebecca","family":"Casari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Metastasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Zamboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martino","family":"Biasioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Campagnari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Lugoboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited\u2013will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction."},{"key":"B2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF00429621","article-title":"Withdrawal reactions from chlordiazepoxide (\u201cLibrium\u201d).","volume":"2","author":"Hollister","year":"1961","journal-title":"Psychopharmacologia."},{"key":"B3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/1355621021000005973","article-title":"Intravenous FLU versus oxazepam tapering in the treatment of BZD withdrawal: a randomized, placebo-controlled study.","volume":"7","author":"Gerra","year":"2002","journal-title":"Addict Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/0269881108100322","article-title":"The role of FLU in the treatment of BZD dependence: physiological and psychological profiles.","volume":"23","author":"Hood","year":"2009","journal-title":"J Psychopharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1177\/0269881116647505","article-title":"Slow subcutaneous infusion of FLU for the treatment of long-term, high-dose BZD users: a review of 214 cases.","volume":"30","author":"Faccini","year":"2016","journal-title":"J Psychopharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.drugalcdep.2009.04.017","article-title":"Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study.","volume":"104","author":"Fang","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"B7","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJMra1611832","article-title":"Treatment of benzodiazepine dependence.","volume":"376","author":"Soyka","year":"2017","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/YIC.0b013e328105e0f2","article-title":"Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies.","volume":"22","author":"Petitjean","year":"2007","journal-title":"Int Clin Psychopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/bcp.12023","article-title":"Benzodiazepine dependence and its treatment with low dose FLU.","volume":"77","author":"Hood","year":"2014","journal-title":"Br J Clin Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.646038","article-title":"Continuous infusion of FLU in the management of benzodiazepines detoxification.","volume":"2021","author":"Benini","year":"2021","journal-title":"Front Psychiatry."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1177\/0269881117714050","article-title":"Low risk of seizures with FLU infusion and routine anticonvulsant prophylaxis for high-dose benzodiazepine dependence.","volume":"31","author":"Tamburin","year":"2017","journal-title":"J Psychophamacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1111\/j.1360-0443.2010.03177.x","article-title":"Benzodiazepine dependence: When abstinence is not an option.","volume":"105","author":"Liebrenz","year":"2010","journal-title":"Addiction"},{"key":"B13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/0269881120981390","article-title":"Pharmacological uses of FLU in benzodiazepine use disorders: a systematic review of limited data.","volume":"35","author":"Gallo","year":"2021","journal-title":"J Psychopharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00004850-199606000-00002","article-title":"Intravenous FLU following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal.","volume":"11","author":"Gerra","year":"1996","journal-title":"Int Clin Psychopharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/0269881112446532","article-title":"Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous FLU infusion for the management of BZD withdrawal: a case series.","volume":"27","author":"Hulse","year":"2013","journal-title":"J Psychopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1177\/0269881114523865","article-title":"Use of subcutaneous FLU preparations for the treatment of idiopathic hypersomnia: a case report.","volume":"28","author":"Kelty","year":"2014","journal-title":"J Psychopharmacol."},{"key":"B17","article-title":"Treatment of benzodiazepine dependence.","volume":"376","author":"Lugoboni","year":"2017","journal-title":"N Eng J Med."},{"year":"2018","key":"B18"},{"key":"B19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.psychres.2012.02.008","article-title":"High dose BZD dependence: description of 29 patients treated with FLU infusion and stabilised with clonazepam.","volume":"198","author":"Quaglio","year":"2012","journal-title":"Psychiatry Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/08897077.2011.638735","article-title":"Megadose bromazepam and zolpidem dependence: two case reports of treatment with FLU and valproate.","volume":"33","author":"Quaglio","year":"2012","journal-title":"Subst Abus."},{"key":"B21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.yic.0000166404.41850.b4","article-title":"Dependence on zolpidem: two case reports of detoxification with FLU infusion.","volume":"20","author":"Quaglio","year":"2005","journal-title":"Int Clin Psychopharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.yebeh.2011.11.005","article-title":"Focal nonconvulsive seizures during detoxification for BZD abuse.","volume":"23","author":"Albiero","year":"2012","journal-title":"Epilepsy Behav."},{"key":"B23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.psychres.2017.02.024","article-title":"N-acetylcysteine for treating cocaine addiction - A systematic review.","volume":"251","author":"Nocito Echevarria","year":"2017","journal-title":"Psychiatry Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1528-1167.2012.03712.x","article-title":"Why are antiepileptic drugs used for nonepileptic conditions?","volume":"53","author":"Bialer","year":"2012","journal-title":"Epilepsia."},{"key":"B25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1517\/17425255.2012.645535","article-title":"Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects.","volume":"8","author":"Jankovic","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4212\/cjhp.v75i1.3254","article-title":"Levetiracetam for status epilepticus in adults: a systematic review.","volume":"75","author":"Webb","year":"2022","journal-title":"Can J Hosp Pharm."},{"key":"B27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000434755","article-title":"Hypnotics and triazolobenzodiazepines-best predictors of high-dose benzodiazepine use: results from the Luxembourg National Health Insurance Registry.","volume":"84","author":"Cloos","year":"2015","journal-title":"Psychother Psychosom."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3238\/arztebl.2015.0001","article-title":"The problems of long-term treatment with benzodiazepines and related substances.","volume":"112","author":"Janhsen","year":"2015","journal-title":"Dtsch Arztebl Int."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1888","article-title":"Benzodiazepine high-doses: the need for an accurate definition.","volume":"30","author":"Cloos","year":"2021","journal-title":"Int J Methods Psychiatr Res."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.857376\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:44:08Z","timestamp":1648730648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.857376\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":29,"alternative-id":["10.3389\/fpsyt.2022.857376"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.857376","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"article-number":"857376"}}